RE:RE:RE:RE:Another look at the dataThe optimized patients effects...
I would not worries to much about the 12 undertreated patients, as more optimized patients are treated, the TR(CR+PR) increase.
TR= number of patients that still have their bladder after TLT cancer treatment.
Exemple, PressRelease AUG 29,2022.
270 day 450 day
Total Response(CR+PR) = 63 % 33 %
The 63% of patients that still have their bladder at 270 day include 18 optimized patients.
Of the 33% of patients that still have their bladder at 450 day, none are optimized patients.
Conclusion
In DEC 2022, 18 optimized patients will have completed their 450 day data.
Consequently in DEC 2022, the 33% TR at 450 day should climb closer to the 270 day 63% TR results.
The FDA know about the optimized patients effects.
Bode well for the BTD approval.